5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
Crossref DOI link: https://doi.org/10.1007/s10552-015-0622-4
Published Online: 2015-06-25
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Robinson, David
Garmo, Hans
Holmberg, Lars
Stattin, Pär
License valid from 2015-06-25